Disease

The Alpha-Gal Primer

This article summarizes an opinion piece in the Proceedings of the National Academy of Science.

The Food and Drug Administration on July 6 granted full approval to the first therapy for Alzheimer’s that slows the cognitive decline associated with the disease.

Let’s start with the disclaimers. Most importantly, “excess” deaths, meaning a higher number than might be anticipated, are based on the assumption that the baseline death used to determine excess was accurate.

Not surprisingly, others have pondered this question as well.

Much of our data comes from the CDC, which collects state-wide data from “Maternal Mortality Review Committees (MMRCs), which are representatives of diverse

During the years of my medical career, when I treated patients (always in hospitals), I was one of those rushed doctors who focused on efficiently formulating and implementing diagnostic and treatment plans rather than on the patient’s emotional n

Where there’s smoke, is there fire?

There is little doubt that beauty is culturally constructed.

The study reported in the Open Forum of Infectious Diseases is based on data contained within the Innovative Support For Patients with SARS-Co-V-2 Infectious Regi